S. Schuster

发表

Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas.

A. Alavi, Rakesh Kumar, I. Maillard, 2004, Radiologic clinics of North America.

Can [F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?

A. Alavi, H. Zhuang, D. Fuster, 2005 .

Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET

A. Alavi, S. Basu, S. Srinivas, 2008, Nuclear medicine communications.

Post‐treatment (not interim) positron emission tomography‐computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R‐HyperCVAD

A. Goy, A. Mato, A. Pecora, 2012, Cancer.

Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.

A. Alavi, R. Talanow, S. Schuster, 2011, Clinical lymphoma, myeloma & leukemia.

Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?

A. Alavi, M. Czuczman, F. Kraeber-Bodéré, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.

F. Kay, C. Nomura, N. Hamerschlak, 2019, Leukemia research.

Feasibility and utility of ROVER software for 3D quantitative image analysis of FDG-PET in patients with diffuse large B-cell lymphoma (DLBCL)

F. Hofheinz, A. Alavi, D. Torigian, 2009 .

Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients.

S. Schuster, D. Sears, R. Means, 1999, Clinical and laboratory haematology.

Bleomycin, Lomustine, Cyclophosphamide, Vincristine, Procarbazine and Prednisone (BLEO-CCVPP) in Patients with Hodgkin's Disease who Relapsed after Radiotherapy Alone: a Long-Term Foliow-Up Study of the Eastern Cooperative Oncology Group (E3481)

T. Habermann, M. Oken, J. Glick, 2001, Leukemia & lymphoma.

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

D. Porter, R. Elstrom, E. Glatstein, 2005, Leukemia & lymphoma.

Utility of FDG-PET scanning in lymphoma by WHO classification.

A. Alavi, A. Bagg, Amit K. Mehrotra, 2003, Blood.

Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.

D. Torigian, A. Mato, S. Schuster, 2008, Clinical nuclear medicine.

Spontaneous Regression of Follicular, Mantle Cell, and Diffuse Large B-Cell Non-Hodgkin's Lymphomas Detected by FDG–PET Imaging

A. Alavi, H. Zhuang, Rakesh Kumar, 2004, Clinical nuclear medicine.

Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow.

A. Alavi, R. Elstrom, J. Vergilio, 2004, Clinical lymphoma.

Primary cardiac lymphoma: Utility of multimodality imaging in diagnosis and management

A. Bagg, A. Morgans, E. Glatstein, 2007, Cancer biology & therapy.

Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging.

D. Mitchell, D. Burk, M. Rifkin, 1991, Radiology.

Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?

Abass Alavi, Stephen Chiang, Hongming Zhuang, 2006, Nuclear medicine communications.

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

T. Brown, F. Howe, J. Griffiths, 2013, Academic Radiology.

Primary lymphomas of the cervix and uterus: The University of Pennsylvania's experience and a review of the literature

R. Elstrom, S. Rubin, C. Andreadis, 2006, Leukemia & lymphoma.

A 65-year-old woman with intractable nasal congestion.

A. Chalian, A. Apter, S. Schuster, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

GM-CSF plus rituximab immunotherapy: Translation of biologic mechanisms into therapy for indolent B-cell lymphomas

P. Venugopal, P. Mclaughlin, S. Schuster, 2008, Leukemia & lymphoma.

Comparison of contrast-enhanced CT (CECT) and FDG-PET/CT for imaging diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

A. Alavi, D. Torigian, A. Mato, 2009 .

Posttransplant lymphoproliferative disorder in adult liver transplant recipients: A report of seventeen cases

K. Olthoff, J. Markmann, A. Shaked, 2007, Leukemia & lymphoma.

Regression of pulmonary MALT lymphoma after treatment with rituximab

A. Alavi, H. Zhuang, C. Andreadis, 2005, Leukemia & lymphoma.

Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography.

A. Alavi, S. Schuster, A. Matthies, 2001, Clinical lymphoma.

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

A. Alavi, D. Porter, R. Elstrom, 2006, Bone Marrow Transplantation.

Detection of relapse in diffuse large B-cell lymphoma (DLBCL) and Hodgkin's lymphoma (HL): Observations and implications for post-remission combined PET and CT images radiologic surveillance

A. Alavi, S. Nasta, S. Schuster, 2007 .

Detection of Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin’s Lymphoma (HL): Observations and Implications for Post-Remission Radiologic Surveillance.

C. Andreadis, S. Nasta, S. Schuster, 2006 .

Post‐treatment (not interim) positron emission tomography‐computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R‐HyperCVAD

A. Goy, A. Mato, A. Pecora, 2012, Cancer.

Detection of Small Bowel Involvement by Mantle Cell Lymphoma on F-18 FDG Positron Emission Tomography

A. Alavi, M. Levine, S. Schuster, 2002, Clinical nuclear medicine.

Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET

A. Alavi, S. Basu, S. Srinivas, 2008, Nuclear medicine communications.